Global Carrier Screening Market By Technology (DNA Sequencing, Microarrays, Polymerase Chain Reaction and Other technology), By End user (Hospital and Clinics, Physician Offices, Reference Laboratories and Other End Users), By Regional Outlook, Industry Analysis Report and Forecast, 2021 - 2027

The Global Carrier Screening Market size is expected to reach $2,501.94 million by 2027, rising at a market growth of 10.81% CAGR during the forecast period.

Carrier screening refers to a type of testing procedure that allows an end-user to know if he/she has a gene for any kind of genetic disorder. Carrier screening is broadly implemented before/during pregnancy for preventing the possibility of passing the disease to the newborn. It is suggested to both the parents go through carrier screening, as the possibility of forwarding the genetic disease grows if the two parents are the carriers of any sort of genetic defect. Factor such as massive adoption of carrier screening before and during pregnancy, due to the rise in awareness regarding the adverse effects associated with the passing of genetic diseases would acts as a growth factor for carrier screening market during the forecast period.

The rise in awareness regarding the possibility of transferring the genetic diseases is seen in the healthcare sector among the end-users. To tackle this, end-users have become more careful, with a desire to detect and avoid these diseases at their early phase. These factors are anticipated to boost the growth and demand for the carrier screening market during the forecast period. In the last couple of years, the overall carrier screening market has seen huge popularity due to its advantages. Moreover, the adoption rate of carrier screening and testing would increase due to the rise in the number of patients with genetic disorders.

COVID-19 Impact Analysis

The onset of the COVID-19 pandemic was in the Wuhan city of China. The disease is occurred by a virus, extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transferred among humans. Since the beginning of the virus in Wuhan, the disease increasingly spread to other regions of the world. In addition, this virus causes several symptoms in patients, which may vary from common symptoms to severe symptoms. For example, common symptoms may include dry cough, fever, and fatigue. Though, several symptoms include problems in breathing or shortness of breath, chest pain or pressure, and loss of speech or movement.

Moreover, the virus has the massive potential of mortality in a geriatric population. In March 2020, the World Health Organization (WHO) declared COVID-19 as a global pandemic and health emergency. Additionally, there are only some vaccines that got emergency approvals for the treatment and prevention of COVID-19. Hence, social distancing is considered the most effective step to curb the spread of the deadly virus. Further, numerous countries globally have embraced stringent lockdown conditions to maintain social distancing norms.

Market Growth Factors:

Well-established Healthcare Infrastructure

Many countries are focusing on building sophisticated healthcare infrastructure which is equipped with advanced screening and treatment procedures. In addition, nations in the developed countries have advanced healthcare infrastructure, which are integrated with different types of carrier screening procedures, thereby propelling the growth and demand for carrier screening techniques across such countries. Moreover, many individuals want to know the possibility of transmission of their genetic or hereditary diseases to their offerings. Therefore, these factors are anticipated to unlock bright growth prospects for the players operating in the overall carrier screening market during the forecasting period.

Increasing cases of genetic diseases

The demand and growth of the carrier screening market would be fueled by the increase in the prevalence of genetic diseases around the globe. This is due to the possibility and severity of these diseases based on the carrier status of parents and their ancestors. The American College of Obstetricians and Gynecologists suggests the testing of all pregnant women and those thinking of motherhood in the near future to recognize the possibilities of these illnesses, specifically cystic fibrosis, fragile X syndrome, and spinal muscular atrophy (SMA), at an early stage.

Marketing Restraining Factor:

Low awareness and lack of trained professionals

As cell therapies are gaining more popularity, the automated processing systems market needs more skilled professionals to carry out these therapies and operate automated systems. However, the dearth of skilled professionals is estimated to hinder the growth of the Carrier Screening Market over the forecast period. In addition, the usage of technologically advanced and highly complicated flow cytometers and spectrophotometers for generating a huge amount of data outputs require knowledge for interpreting and reviewing would hinder the market growth.

Type Outlook

Based on carrier screening type, the market is segregated into expanded carrier screening and targeted disease carrier screening. The expanded carrier screening segment procured the maximum revenue share of the overall carrier screening market in 2020. This is credited to the constant development in a polymerase chain reaction, sequencing, microarrays, and other similar technologies in the domain of carrier screening. In addition, the market is likely to witness new growth avenues due to the rising cases of genetic disorders.

Technology Outlook

Based on technology, the carrier screening market is divided into DNA sequencing, microarrays, polymerase chain reaction, and other technologies. In 2020, the DNA sequencing segment acquired the largest revenue share of the overall carrier screening market. The segment would emerge as the leading segment during the forecasting period. This is credited to the constant developments in genetic analysis tools, like assays built on next-generation sequencing and microarray technologies, molecular diagnostics, and advancing the kind for heritable disorders.

End-User Outlook

Based on end-user, the market is segmented into hospitals & clinics, reference laboratories, physician offices, and others. The hospital & clinics segment garnered the largest revenue share in the overall carrier screening market in 2020. Moreover, the segment is likely to showcase a similar kind of trend even during the forecast period. Factors such as the growing occurrence of genetic disorders and developments in carrier screening are likely to propel the growth of this segment.

Carrier Screening Market Report Coverage

Report Attribute	Details
Market size value in 2020	USD 1,052.8 Million
Market size forecast in 2027	USD 2,501.94 Million
Base Year	2020
Historical Period	2017 to 2019
Forecast Period	2021 to 2027
Revenue Growth Rate	CAGR of 10.81% from 2021 to 2027
Number of Pages	193
Number of Tables	340
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Type, Technology, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Well-established Healthcare Infrastructure Increasing cases of genetic diseases
Restraints	Low awareness and lack of trained professionals

Regional Outlook

Based on the Region, the carrier screening market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America emerged as the leading region by obtaining the biggest revenue share of the overall carrier screening market in 2020. Moreover, the regional market would showcase a similar kind of trend even during the forecast period. Factors such as the rising occurrence of pulmonary conditions, hematological conditions, and neurological conditions in the region are responsible for the massive growth of the regional market.

Free Valuable Insights: Global Carrier Screening Market size to reach USD 2,501.94 Million by 2027

KBV Cardinal Matrix - Carrier Screening Market Competition Analysis

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Thermo Fisher Scientific is the forerunner in the Carrier Screening Market. Companies such as Quest Diagnostics, Eurofins Scientific, Illumina, Inc. are some of the key innovators in Carrier Screening Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics, Incorporated, Thermo Fisher Scientific, Illumina, Inc., Eurofins Scientific Group, Invitae Corporation, OPKO Health, Inc., Fulgent Genetics, Sema4 OpCo, Inc., Myriad Genetics, Inc., and Natera, Inc.

Recent Strategies Deployed in Carrier Screening Market

» Partnerships, Collaborations and Agreements:

• May-2021: Illumina collaborated with Next Generation Genomic, an association of the Association of Southeast Asian Nations (ASEAN) leaders in laboratory services and reproductive science. Through this collaboration, the two entities introduced VeriSeq NIPT Solution v2 in Thailand, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT).
• Mar-2021: Natera joined hands with Tesis Labs, a US multi-region lab services provider with labs in Colorado, Texas, and Arizona. The collaboration aimed to enable Tesis to widen its portfolio of genetic testing offerings and participate in the fast-growing screening market of above 4 million pregnancies across the US. Moreover, the ultra-modern and extremely scalable genetics laboratory of Tesis in Lafayette, Colorado can serve many parts of the U.S. including Texas, Arizona, and Colorado.
• Jan-2021: Myriad Genetics teamed up with Illumina, a company that develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Through this collaboration, Illumina would develop a kit-based version of the myChoice companion diagnostic (CDx) test for international markets. The collaboration would integrate companion diagnostics and next-generation sequencing to expedite comprehensive genomic profiling of tumor samples and boost enhanced results in oncology.

» Acquisitions and Mergers:

• Aug-2021: BioReference Laboratories took over Ariosa's centralized laboratory prenatal testing business of the US from Roche. The acquisition would help BioReference Laboratories' NIPS offerings and further increase its focus on prenatal screening, enabling BioReference and GenPath to develop high-quality and accessible testing that enhances medical care and results of patients and their families.
• Aug-2021: Fulgent Genetics completed the acquisition of CSI Laboratories, a patient-focused model of cancer diagnostic testing for pathologists, community hospitals, and their patients. The acquisition aimed to help CSI substantially expand its capabilities in molecular diagnostics and oncologic testing. Moreover, Fulgent would harness the potential of its established technology platform, lab operations, NGS expertise, and sales infrastructure along with CSI’s broad cancer testing capabilities to set up a differentiated foothold in oncologic testing across the US.
• Aug-2021: Illumina acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers. Through this acquisition, the company aimed to expedite access and adoption of this life-saving test across the world.
• Jun-2021: Eurofins Clinical Testing US, a subsidiary of Eurofins Scientific, signed an agreement to acquire DNA Diagnostics Center, the leading provider of DNA and paternity testing. Through this acquisition, the company aimed to expedite its vision to enter into a consumer genetic testing segment that supports customized lifestyle and health awareness.
• Jan-2020: Quest Diagnostics completed the acquisition of Blueprint Genetics, a company that provides complete genetic testing and genetic diagnostics to medical professionals around the world. Following the acquisition, the two companies would increase access to valuable insights in genetic and rare diseases, enhancing patient care and pharmaceutical drug research and development.

» Product Launches and Product Expansions:

• Sep-2021: Sema4 launched Sema4 Elements, a line of information-driven genomic solutions, digital tools for patients and vendors, and services that allow vendors to treat patients holistically throughout their reproductive and generational health journey. The product line of the Sema4 Elements portfolio includes solutions for the diagnosis, treatment, and management of preventive, reproductive, and family care.
• Aug-2020: Quest Diagnostics rolled out AncestryHealth with the help of its Ancestry, a rapid and cost-effective way to carry out next-generation sequencing (NGS). Through this launch, company aimed to offer a genetic screening of risks for an expanded set of health conditions like heart disease, colon cancer, breast cancer, and blood disorders.
• Feb-2020: Thermo Fisher Scientific launched a new next-generation sequencing (NGS)-based solution. Through this solution, the company would allow reproductive health researchers to more effectively examine a wide range of key genetic markers with an end-to-end workflow. The CarrierSeq ECS Kit comprises a 420-gene, AmpliSeq-based panel that integrates various stand-alone tests into a single assay.

Scope of the Study

Market Segments Covered in the Report:

By Type

• Expanded Carrier Screening and
• Targeted Disease Carrier Screening

By Technology

• DNA Sequencing
• Microarrays
• Polymerase Chain Reaction and
• Other technology

By End User

• Hospital and Clinics
• Physician Offices
• Reference Laboratories and
• Other End Users

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Quest Diagnostics, Incorporated
• Thermo Fisher Scientific
• Illumina, Inc.
• Eurofins Scientific Group
• Invitae Corporation
• OPKO Health, Inc.
• Fulgent Genetics
• Sema4 OpCo, Inc.
• Myriad Genetics, Inc.
• Natera, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Carrier Screening Market, by Type
1.4.2 Global Carrier Screening Market, by Technology
1.4.3 Global Carrier Screening Market, by End User
1.4.4 Global Carrier Screening Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Jun – 2021, Jun) Leading Players

Chapter 4. Global Carrier Screening Market by Type
4.1 Global Expanded Carrier Screening Market by Region
4.2 Global Targeted Disease Carrier Screening Market by Region
4.3 Global Carrier Screening Market by Technology
4.4 Global DNA Sequencing Market by Region
4.5 Global Microarrays Market by Region
4.6 Global Polymerase Chain Reaction Market by Region
4.7 Global Other Technologies Market by Region

Chapter 5. Global Carrier Screening Market by End user
5.1 Global Hospital and Clinics Market by Region
5.2 Global Physician Offices Market by Region
5.3 Global Reference Laboratories Market by Region
5.4 Global Other End user Market by Region

Chapter 6. Global Carrier Screening Market by Region
6.1 North America Carrier Screening Market
6.1.1 North America Carrier Screening Market by Type
6.1.1.1 North America Expanded Carrier Screening Market by Country
6.1.1.2 North America Targeted Disease Carrier Screening Market by Country
6.1.2 North America Carrier Screening Market by Technology
6.1.2.1 North America DNA Sequencing Market by Country
6.1.2.2 North America Microarrays Market by Country
6.1.2.3 North America Polymerase Chain Reaction Market by Country
6.1.2.4 North America Other Technologies Market by Country
6.1.3 North America Carrier Screening Market by End user
6.1.3.1 North America Hospital and Clinics Market by Country
6.1.3.2 North America Physician Offices Market by Country
6.1.3.3 North America Reference Laboratories Market by Country
6.1.3.4 North America Other End user Market by Country
6.1.4 North America Carrier Screening Market by Country
6.1.4.1 USA Carrier Screening Market
6.1.4.1.1 USA Carrier Screening Market by Type
6.1.4.1.2 USA Carrier Screening Market by Technology
6.1.4.1.3 USA Carrier Screening Market by End user
6.1.4.2 Canada Carrier Screening Market
6.1.4.2.1 Canada Carrier Screening Market by Type
6.1.4.2.2 Canada Carrier Screening Market by Technology
6.1.4.2.3 Canada Carrier Screening Market by End user
6.1.4.3 Mexico Carrier Screening Market
6.1.4.3.1 Mexico Carrier Screening Market by Type
6.1.4.3.2 Mexico Carrier Screening Market by Technology
6.1.4.3.3 Mexico Carrier Screening Market by End user
6.1.4.4 Rest of North America Carrier Screening Market
6.1.4.4.1 Rest of North America Carrier Screening Market by Type
6.1.4.4.2 Rest of North America Carrier Screening Market by Technology
6.1.4.4.3 Rest of North America Carrier Screening Market by End user
6.2 Europe Carrier Screening Market
6.2.1 Europe Carrier Screening Market by Type
6.2.1.1 Europe Expanded Carrier Screening Market by Country
6.2.1.2 Europe Targeted Disease Carrier Screening Market by Country
6.2.2 Europe Carrier Screening Market by Technology
6.2.2.1 Europe DNA Sequencing Market by Country
6.2.2.2 Europe Microarrays Market by Country
6.2.2.3 Europe Polymerase Chain Reaction Market by Country
6.2.2.4 Europe Other Technologies Market by Country
6.2.3 Europe Carrier Screening Market by End user
6.2.3.1 Europe Hospital and Clinics Market by Country
6.2.3.2 Europe Physician Offices Market by Country
6.2.3.3 Europe Reference Laboratories Market by Country
6.2.3.4 Europe Other End user Market by Country
6.2.4 Europe Carrier Screening Market by Country
6.2.4.1 Germany Carrier Screening Market
6.2.4.1.1 Germany Carrier Screening Market by Type
6.2.4.1.2 Germany Carrier Screening Market by Technology
6.2.4.1.3 Germany Carrier Screening Market by End user
6.2.4.2 UK Carrier Screening Market
6.2.4.2.1 UK Carrier Screening Market by Type
6.2.4.2.2 UK Carrier Screening Market by Technology
6.2.4.2.3 UK Carrier Screening Market by End user
6.2.4.3 France Carrier Screening Market
6.2.4.3.1 France Carrier Screening Market by Type
6.2.4.3.2 France Carrier Screening Market by Technology
6.2.4.3.3 France Carrier Screening Market by End user
6.2.4.4 Russia Carrier Screening Market
6.2.4.4.1 Russia Carrier Screening Market by Type
6.2.4.4.2 Russia Carrier Screening Market by Technology
6.2.4.4.3 Russia Carrier Screening Market by End user
6.2.4.5 Spain Carrier Screening Market
6.2.4.5.1 Spain Carrier Screening Market by Type
6.2.4.5.2 Spain Carrier Screening Market by Technology
6.2.4.5.3 Spain Carrier Screening Market by End user
6.2.4.6 Italy Carrier Screening Market
6.2.4.6.1 Italy Carrier Screening Market by Type
6.2.4.6.2 Italy Carrier Screening Market by Technology
6.2.4.6.3 Italy Carrier Screening Market by End user
6.2.4.7 Rest of Europe Carrier Screening Market
6.2.4.7.1 Rest of Europe Carrier Screening Market by Type
6.2.4.7.2 Rest of Europe Carrier Screening Market by Technology
6.2.4.7.3 Rest of Europe Carrier Screening Market by End user
6.3 Asia Pacific Carrier Screening Market
6.3.1 Asia Pacific Carrier Screening Market by Type
6.3.1.1 Asia Pacific Expanded Carrier Screening Market by Country
6.3.1.2 Asia Pacific Targeted Disease Carrier Screening Market by Country
6.3.2 Asia Pacific Carrier Screening Market by Technology
6.3.2.1 Asia Pacific DNA Sequencing Market by Country
6.3.2.2 Asia Pacific Microarrays Market by Country
6.3.2.3 Asia Pacific Polymerase Chain Reaction Market by Country
6.3.2.4 Asia Pacific Other Technologies Market by Country
6.3.3 Asia Pacific Carrier Screening Market by End user
6.3.3.1 Asia Pacific Hospital and Clinics Market by Country
6.3.3.2 Asia Pacific Physician Offices Market by Country
6.3.3.3 Asia Pacific Reference Laboratories Market by Country
6.3.3.4 Asia Pacific Other End user Market by Country
6.3.4 Asia Pacific Carrier Screening Market by Country
6.3.4.1 China Carrier Screening Market
6.3.4.1.1 China Carrier Screening Market by Type
6.3.4.1.2 China Carrier Screening Market by Technology
6.3.4.1.3 China Carrier Screening Market by End user
6.3.4.2 Japan Carrier Screening Market
6.3.4.2.1 Japan Carrier Screening Market by Type
6.3.4.2.2 Japan Carrier Screening Market by Technology
6.3.4.2.3 Japan Carrier Screening Market by End user
6.3.4.3 India Carrier Screening Market
6.3.4.3.1 India Carrier Screening Market by Type
6.3.4.3.2 India Carrier Screening Market by Technology
6.3.4.3.3 India Carrier Screening Market by End user
6.3.4.4 South Korea Carrier Screening Market
6.3.4.4.1 South Korea Carrier Screening Market by Type
6.3.4.4.2 South Korea Carrier Screening Market by Technology
6.3.4.4.3 South Korea Carrier Screening Market by End user
6.3.4.5 Singapore Carrier Screening Market
6.3.4.5.1 Singapore Carrier Screening Market by Type
6.3.4.5.2 Singapore Carrier Screening Market by Technology
6.3.4.5.3 Singapore Carrier Screening Market by End user
6.3.4.6 Malaysia Carrier Screening Market
6.3.4.6.1 Malaysia Carrier Screening Market by Type
6.3.4.6.2 Malaysia Carrier Screening Market by Technology
6.3.4.6.3 Malaysia Carrier Screening Market by End user
6.3.4.7 Rest of Asia Pacific Carrier Screening Market
6.3.4.7.1 Rest of Asia Pacific Carrier Screening Market by Type
6.3.4.7.2 Rest of Asia Pacific Carrier Screening Market by Technology
6.3.4.7.3 Rest of Asia Pacific Carrier Screening Market by End user
6.4 LAMEA Carrier Screening Market
6.4.1 LAMEA Carrier Screening Market by Type
6.4.1.1 LAMEA Expanded Carrier Screening Market by Country
6.4.1.2 LAMEA Targeted Disease Carrier Screening Market by Country
6.4.2 LAMEA Carrier Screening Market by Technology
6.4.2.1 LAMEA DNA Sequencing Market by Country
6.4.2.2 LAMEA Microarrays Market by Country
6.4.2.3 LAMEA Polymerase Chain Reaction Market by Country
6.4.2.4 LAMEA Other Technologies Market by Country
6.4.3 LAMEA Carrier Screening Market by End user
6.4.3.1 LAMEA Hospital and Clinics Market by Country
6.4.3.2 LAMEA Physician Offices Market by Country
6.4.3.3 LAMEA Reference Laboratories Market by Country
6.4.3.4 LAMEA Other End user Market by Country
6.4.4 LAMEA Carrier Screening Market by Country
6.4.4.1 Brazil Carrier Screening Market
6.4.4.1.1 Brazil Carrier Screening Market by Type
6.4.4.1.2 Brazil Carrier Screening Market by Technology
6.4.4.1.3 Brazil Carrier Screening Market by End user
6.4.4.2 Argentina Carrier Screening Market
6.4.4.2.1 Argentina Carrier Screening Market by Type
6.4.4.2.2 Argentina Carrier Screening Market by Technology
6.4.4.2.3 Argentina Carrier Screening Market by End user
6.4.4.3 UAE Carrier Screening Market
6.4.4.3.1 UAE Carrier Screening Market by Type
6.4.4.3.2 UAE Carrier Screening Market by Technology
6.4.4.3.3 UAE Carrier Screening Market by End user
6.4.4.4 Saudi Arabia Carrier Screening Market
6.4.4.4.1 Saudi Arabia Carrier Screening Market by Type
6.4.4.4.2 Saudi Arabia Carrier Screening Market by Technology
6.4.4.4.3 Saudi Arabia Carrier Screening Market by End user
6.4.4.5 South Africa Carrier Screening Market
6.4.4.5.1 South Africa Carrier Screening Market by Type
6.4.4.5.2 South Africa Carrier Screening Market by Technology
6.4.4.5.3 South Africa Carrier Screening Market by End user
6.4.4.6 Nigeria Carrier Screening Market
6.4.4.6.1 Nigeria Carrier Screening Market by Type
6.4.4.6.2 Nigeria Carrier Screening Market by Technology
6.4.4.6.3 Nigeria Carrier Screening Market by End user
6.4.4.7 Rest of LAMEA Carrier Screening Market
6.4.4.7.1 Rest of LAMEA Carrier Screening Market by Type
6.4.4.7.2 Rest of LAMEA Carrier Screening Market by Technology
6.4.4.7.3 Rest of LAMEA Carrier Screening Market by End user

Chapter 7. Company Profiles
7.1 Quest Diagnostics, Incorporated
7.1.1 Company Overview
7.1.1 Financial Analysis
7.1.2 Recent strategies and developments:
7.1.2.1 Partnerships, Collaborations, and Agreements:
7.1.2.2 Product Launches and Product Expansions:
7.1.2.3 Acquisition and Mergers:
7.2 Thermo Fisher Scientific, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Product Launches and Product Expansions:
7.2.6 SWOT Analysis
7.3 Illumina, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Acquisition and Mergers:
7.4 Eurofins Scientific Group
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Recent strategies and developments:
7.4.4.1 Partnerships, Collaborations, and Agreements:
7.4.4.2 Acquisition and Mergers:
7.5 Invitae Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Product Launches and Product Expansions:
7.5.5.2 Acquisition and Mergers:
7.6 OPKO Health, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Acquisition and Mergers:
7.7 Fulgent Genetics
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Acquisition and Mergers:
7.8 Sema4 OpCo, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
7.8.2.2 Product Launches and Product Expansions:
7.9 Myriad Genetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Product Launches and Product Expansions:
7.1 Natera Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Partnerships, Collaborations, and Agreements:
7.10.5.2 Product Launches and Product Expansions:

TABLE 1 Global Carrier Screening Market, 2017 - 2020, USD Million
TABLE 2 Global Carrier Screening Market, 2021 - 2027, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Carrier Screening Market
TABLE 4 Product Launches And Product Expansions– Carrier Screening Market
TABLE 5 Acquisition and Mergers– Carrier Screening Market
TABLE 6 Global Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 7 Global Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 8 Global Expanded Carrier Screening Market by Region, 2017 - 2020, USD Million
TABLE 9 Global Expanded Carrier Screening Market by Region, 2021 - 2027, USD Million
TABLE 10 Global Targeted Disease Carrier Screening Market by Region, 2017 - 2020, USD Million
TABLE 11 Global Targeted Disease Carrier Screening Market by Region, 2021 - 2027, USD Million
TABLE 12 Global Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 13 Global Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 14 Global DNA Sequencing Market by Region, 2017 - 2020, USD Million
TABLE 15 Global DNA Sequencing Market by Region, 2021 - 2027, USD Million
TABLE 16 Global Microarrays Market by Region, 2017 - 2020, USD Million
TABLE 17 Global Microarrays Market by Region, 2021 - 2027, USD Million
TABLE 18 Global Polymerase Chain Reaction Market by Region, 2017 - 2020, USD Million
TABLE 19 Global Polymerase Chain Reaction Market by Region, 2021 - 2027, USD Million
TABLE 20 Global Other Technologies Market by Region, 2017 - 2020, USD Million
TABLE 21 Global Other Technologies Market by Region, 2021 - 2027, USD Million
TABLE 22 Global Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 23 Global Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 24 Global Hospital and Clinics Market by Region, 2017 - 2020, USD Million
TABLE 25 Global Hospital and Clinics Market by Region, 2021 - 2027, USD Million
TABLE 26 Global Physician Offices Market by Region, 2017 - 2020, USD Million
TABLE 27 Global Physician Offices Market by Region, 2021 - 2027, USD Million
TABLE 28 Global Reference Laboratories Market by Region, 2017 - 2020, USD Million
TABLE 29 Global Reference Laboratories Market by Region, 2021 - 2027, USD Million
TABLE 30 Global Other End user Market by Region, 2017 - 2020, USD Million
TABLE 31 Global Other End user Market by Region, 2021 - 2027, USD Million
TABLE 32 Global Carrier Screening Market by Region, 2017 - 2020, USD Million
TABLE 33 Global Carrier Screening Market by Region, 2021 - 2027, USD Million
TABLE 34 North America Carrier Screening Market, 2017 - 2020, USD Million
TABLE 35 North America Carrier Screening Market, 2021 - 2027, USD Million
TABLE 36 North America Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 37 North America Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 38 North America Expanded Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 39 North America Expanded Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 40 North America Targeted Disease Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 41 North America Targeted Disease Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 42 North America Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 43 North America Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 44 North America DNA Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 45 North America DNA Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 46 North America Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 47 North America Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 48 North America Polymerase Chain Reaction Market by Country, 2017 - 2020, USD Million
TABLE 49 North America Polymerase Chain Reaction Market by Country, 2021 - 2027, USD Million
TABLE 50 North America Other Technologies Market by Country, 2017 - 2020, USD Million
TABLE 51 North America Other Technologies Market by Country, 2021 - 2027, USD Million
TABLE 52 North America Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 53 North America Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 54 North America Hospital and Clinics Market by Country, 2017 - 2020, USD Million
TABLE 55 North America Hospital and Clinics Market by Country, 2021 - 2027, USD Million
TABLE 56 North America Physician Offices Market by Country, 2017 - 2020, USD Million
TABLE 57 North America Physician Offices Market by Country, 2021 - 2027, USD Million
TABLE 58 North America Reference Laboratories Market by Country, 2017 - 2020, USD Million
TABLE 59 North America Reference Laboratories Market by Country, 2021 - 2027, USD Million
TABLE 60 North America Other End user Market by Country, 2017 - 2020, USD Million
TABLE 61 North America Other End user Market by Country, 2021 - 2027, USD Million
TABLE 62 North America Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 63 North America Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 64 USA Carrier Screening Market, 2017 - 2020, USD Million
TABLE 65 USA Carrier Screening Market, 2021 - 2027, USD Million
TABLE 66 USA Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 67 USA Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 68 USA Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 69 USA Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 70 USA Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 71 USA Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 72 Canada Carrier Screening Market, 2017 - 2020, USD Million
TABLE 73 Canada Carrier Screening Market, 2021 - 2027, USD Million
TABLE 74 Canada Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 75 Canada Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 76 Canada Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 77 Canada Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 78 Canada Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 79 Canada Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 80 Mexico Carrier Screening Market, 2017 - 2020, USD Million
TABLE 81 Mexico Carrier Screening Market, 2021 - 2027, USD Million
TABLE 82 Mexico Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 83 Mexico Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 84 Mexico Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 85 Mexico Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 86 Mexico Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 87 Mexico Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 88 Rest of North America Carrier Screening Market, 2017 - 2020, USD Million
TABLE 89 Rest of North America Carrier Screening Market, 2021 - 2027, USD Million
TABLE 90 Rest of North America Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 91 Rest of North America Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 92 Rest of North America Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 93 Rest of North America Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 94 Rest of North America Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 95 Rest of North America Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 96 Europe Carrier Screening Market, 2017 - 2020, USD Million
TABLE 97 Europe Carrier Screening Market, 2021 - 2027, USD Million
TABLE 98 Europe Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 99 Europe Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 100 Europe Expanded Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 101 Europe Expanded Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 102 Europe Targeted Disease Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 103 Europe Targeted Disease Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 104 Europe Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 105 Europe Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 106 Europe DNA Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 107 Europe DNA Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 108 Europe Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 109 Europe Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 110 Europe Polymerase Chain Reaction Market by Country, 2017 - 2020, USD Million
TABLE 111 Europe Polymerase Chain Reaction Market by Country, 2021 - 2027, USD Million
TABLE 112 Europe Other Technologies Market by Country, 2017 - 2020, USD Million
TABLE 113 Europe Other Technologies Market by Country, 2021 - 2027, USD Million
TABLE 114 Europe Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 115 Europe Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 116 Europe Hospital and Clinics Market by Country, 2017 - 2020, USD Million
TABLE 117 Europe Hospital and Clinics Market by Country, 2021 - 2027, USD Million
TABLE 118 Europe Physician Offices Market by Country, 2017 - 2020, USD Million
TABLE 119 Europe Physician Offices Market by Country, 2021 - 2027, USD Million
TABLE 120 Europe Reference Laboratories Market by Country, 2017 - 2020, USD Million
TABLE 121 Europe Reference Laboratories Market by Country, 2021 - 2027, USD Million
TABLE 122 Europe Other End user Market by Country, 2017 - 2020, USD Million
TABLE 123 Europe Other End user Market by Country, 2021 - 2027, USD Million
TABLE 124 Europe Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 125 Europe Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 126 Germany Carrier Screening Market, 2017 - 2020, USD Million
TABLE 127 Germany Carrier Screening Market, 2021 - 2027, USD Million
TABLE 128 Germany Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 129 Germany Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 130 Germany Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 131 Germany Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 132 Germany Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 133 Germany Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 134 UK Carrier Screening Market, 2017 - 2020, USD Million
TABLE 135 UK Carrier Screening Market, 2021 - 2027, USD Million
TABLE 136 UK Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 137 UK Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 138 UK Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 139 UK Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 140 UK Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 141 UK Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 142 France Carrier Screening Market, 2017 - 2020, USD Million
TABLE 143 France Carrier Screening Market, 2021 - 2027, USD Million
TABLE 144 France Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 145 France Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 146 France Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 147 France Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 148 France Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 149 France Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 150 Russia Carrier Screening Market, 2017 - 2020, USD Million
TABLE 151 Russia Carrier Screening Market, 2021 - 2027, USD Million
TABLE 152 Russia Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 153 Russia Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 154 Russia Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 155 Russia Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 156 Russia Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 157 Russia Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 158 Spain Carrier Screening Market, 2017 - 2020, USD Million
TABLE 159 Spain Carrier Screening Market, 2021 - 2027, USD Million
TABLE 160 Spain Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 161 Spain Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 162 Spain Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 163 Spain Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 164 Spain Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 165 Spain Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 166 Italy Carrier Screening Market, 2017 - 2020, USD Million
TABLE 167 Italy Carrier Screening Market, 2021 - 2027, USD Million
TABLE 168 Italy Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 169 Italy Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 170 Italy Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 171 Italy Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 172 Italy Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 173 Italy Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 174 Rest of Europe Carrier Screening Market, 2017 - 2020, USD Million
TABLE 175 Rest of Europe Carrier Screening Market, 2021 - 2027, USD Million
TABLE 176 Rest of Europe Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 177 Rest of Europe Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 178 Rest of Europe Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 179 Rest of Europe Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 180 Rest of Europe Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 181 Rest of Europe Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 182 Asia Pacific Carrier Screening Market, 2017 - 2020, USD Million
TABLE 183 Asia Pacific Carrier Screening Market, 2021 - 2027, USD Million
TABLE 184 Asia Pacific Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 185 Asia Pacific Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 186 Asia Pacific Expanded Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 187 Asia Pacific Expanded Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 188 Asia Pacific Targeted Disease Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 189 Asia Pacific Targeted Disease Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 190 Asia Pacific Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 191 Asia Pacific Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 192 Asia Pacific DNA Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 193 Asia Pacific DNA Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 194 Asia Pacific Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 195 Asia Pacific Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 196 Asia Pacific Polymerase Chain Reaction Market by Country, 2017 - 2020, USD Million
TABLE 197 Asia Pacific Polymerase Chain Reaction Market by Country, 2021 - 2027, USD Million
TABLE 198 Asia Pacific Other Technologies Market by Country, 2017 - 2020, USD Million
TABLE 199 Asia Pacific Other Technologies Market by Country, 2021 - 2027, USD Million
TABLE 200 Asia Pacific Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 201 Asia Pacific Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 202 Asia Pacific Hospital and Clinics Market by Country, 2017 - 2020, USD Million
TABLE 203 Asia Pacific Hospital and Clinics Market by Country, 2021 - 2027, USD Million
TABLE 204 Asia Pacific Physician Offices Market by Country, 2017 - 2020, USD Million
TABLE 205 Asia Pacific Physician Offices Market by Country, 2021 - 2027, USD Million
TABLE 206 Asia Pacific Reference Laboratories Market by Country, 2017 - 2020, USD Million
TABLE 207 Asia Pacific Reference Laboratories Market by Country, 2021 - 2027, USD Million
TABLE 208 Asia Pacific Other End user Market by Country, 2017 - 2020, USD Million
TABLE 209 Asia Pacific Other End user Market by Country, 2021 - 2027, USD Million
TABLE 210 Asia Pacific Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 211 Asia Pacific Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 212 China Carrier Screening Market, 2017 - 2020, USD Million
TABLE 213 China Carrier Screening Market, 2021 - 2027, USD Million
TABLE 214 China Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 215 China Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 216 China Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 217 China Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 218 China Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 219 China Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 220 Japan Carrier Screening Market, 2017 - 2020, USD Million
TABLE 221 Japan Carrier Screening Market, 2021 - 2027, USD Million
TABLE 222 Japan Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 223 Japan Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 224 Japan Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 225 Japan Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 226 Japan Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 227 Japan Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 228 India Carrier Screening Market, 2017 - 2020, USD Million
TABLE 229 India Carrier Screening Market, 2021 - 2027, USD Million
TABLE 230 India Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 231 India Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 232 India Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 233 India Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 234 India Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 235 India Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 236 South Korea Carrier Screening Market, 2017 - 2020, USD Million
TABLE 237 South Korea Carrier Screening Market, 2021 - 2027, USD Million
TABLE 238 South Korea Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 239 South Korea Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 240 South Korea Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 241 South Korea Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 242 South Korea Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 243 South Korea Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 244 Singapore Carrier Screening Market, 2017 - 2020, USD Million
TABLE 245 Singapore Carrier Screening Market, 2021 - 2027, USD Million
TABLE 246 Singapore Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 247 Singapore Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 248 Singapore Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 249 Singapore Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 250 Singapore Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 251 Singapore Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 252 Malaysia Carrier Screening Market, 2017 - 2020, USD Million
TABLE 253 Malaysia Carrier Screening Market, 2021 - 2027, USD Million
TABLE 254 Malaysia Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 255 Malaysia Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 256 Malaysia Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 257 Malaysia Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 258 Malaysia Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 259 Malaysia Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 260 Rest of Asia Pacific Carrier Screening Market, 2017 - 2020, USD Million
TABLE 261 Rest of Asia Pacific Carrier Screening Market, 2021 - 2027, USD Million
TABLE 262 Rest of Asia Pacific Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 263 Rest of Asia Pacific Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 264 Rest of Asia Pacific Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 265 Rest of Asia Pacific Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 266 Rest of Asia Pacific Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 267 Rest of Asia Pacific Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 268 LAMEA Carrier Screening Market, 2017 - 2020, USD Million
TABLE 269 LAMEA Carrier Screening Market, 2021 - 2027, USD Million
TABLE 270 LAMEA Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 271 LAMEA Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 272 LAMEA Expanded Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 273 LAMEA Expanded Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 274 LAMEA Targeted Disease Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 275 LAMEA Targeted Disease Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 276 LAMEA Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 277 LAMEA Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 278 LAMEA DNA Sequencing Market by Country, 2017 - 2020, USD Million
TABLE 279 LAMEA DNA Sequencing Market by Country, 2021 - 2027, USD Million
TABLE 280 LAMEA Microarrays Market by Country, 2017 - 2020, USD Million
TABLE 281 LAMEA Microarrays Market by Country, 2021 - 2027, USD Million
TABLE 282 LAMEA Polymerase Chain Reaction Market by Country, 2017 - 2020, USD Million
TABLE 283 LAMEA Polymerase Chain Reaction Market by Country, 2021 - 2027, USD Million
TABLE 284 LAMEA Other Technologies Market by Country, 2017 - 2020, USD Million
TABLE 285 LAMEA Other Technologies Market by Country, 2021 - 2027, USD Million
TABLE 286 LAMEA Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 287 LAMEA Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 288 LAMEA Hospital and Clinics Market by Country, 2017 - 2020, USD Million
TABLE 289 LAMEA Hospital and Clinics Market by Country, 2021 - 2027, USD Million
TABLE 290 LAMEA Physician Offices Market by Country, 2017 - 2020, USD Million
TABLE 291 LAMEA Physician Offices Market by Country, 2021 - 2027, USD Million
TABLE 292 LAMEA Reference Laboratories Market by Country, 2017 - 2020, USD Million
TABLE 293 LAMEA Reference Laboratories Market by Country, 2021 - 2027, USD Million
TABLE 294 LAMEA Other End user Market by Country, 2017 - 2020, USD Million
TABLE 295 LAMEA Other End user Market by Country, 2021 - 2027, USD Million
TABLE 296 LAMEA Carrier Screening Market by Country, 2017 - 2020, USD Million
TABLE 297 LAMEA Carrier Screening Market by Country, 2021 - 2027, USD Million
TABLE 298 Brazil Carrier Screening Market, 2017 - 2020, USD Million
TABLE 299 Brazil Carrier Screening Market, 2021 - 2027, USD Million
TABLE 300 Brazil Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 301 Brazil Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 302 Brazil Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 303 Brazil Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 304 Brazil Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 305 Brazil Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 306 Argentina Carrier Screening Market, 2017 - 2020, USD Million
TABLE 307 Argentina Carrier Screening Market, 2021 - 2027, USD Million
TABLE 308 Argentina Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 309 Argentina Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 310 Argentina Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 311 Argentina Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 312 Argentina Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 313 Argentina Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 314 UAE Carrier Screening Market, 2017 - 2020, USD Million
TABLE 315 UAE Carrier Screening Market, 2021 - 2027, USD Million
TABLE 316 UAE Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 317 UAE Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 318 UAE Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 319 UAE Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 320 UAE Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 321 UAE Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 322 Saudi Arabia Carrier Screening Market, 2017 - 2020, USD Million
TABLE 323 Saudi Arabia Carrier Screening Market, 2021 - 2027, USD Million
TABLE 324 Saudi Arabia Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 325 Saudi Arabia Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 326 Saudi Arabia Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 327 Saudi Arabia Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 328 Saudi Arabia Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 329 Saudi Arabia Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 330 South Africa Carrier Screening Market, 2017 - 2020, USD Million
TABLE 331 South Africa Carrier Screening Market, 2021 - 2027, USD Million
TABLE 332 South Africa Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 333 South Africa Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 334 South Africa Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 335 South Africa Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 336 South Africa Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 337 South Africa Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 338 Nigeria Carrier Screening Market, 2017 - 2020, USD Million
TABLE 339 Nigeria Carrier Screening Market, 2021 - 2027, USD Million
TABLE 340 Nigeria Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 341 Nigeria Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 342 Nigeria Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 343 Nigeria Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 344 Nigeria Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 345 Nigeria Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 346 Rest of LAMEA Carrier Screening Market, 2017 - 2020, USD Million
TABLE 347 Rest of LAMEA Carrier Screening Market, 2021 - 2027, USD Million
TABLE 348 Rest of LAMEA Carrier Screening Market by Type, 2017 - 2020, USD Million
TABLE 349 Rest of LAMEA Carrier Screening Market by Type, 2021 - 2027, USD Million
TABLE 350 Rest of LAMEA Carrier Screening Market by Technology, 2017 - 2020, USD Million
TABLE 351 Rest of LAMEA Carrier Screening Market by Technology, 2021 - 2027, USD Million
TABLE 352 Rest of LAMEA Carrier Screening Market by End user, 2017 - 2020, USD Million
TABLE 353 Rest of LAMEA Carrier Screening Market by End user, 2021 - 2027, USD Million
TABLE 354 Key Information – Quest Diagnostics, Incorporated
TABLE 355 Key Information – Thermo Fisher Scientific, Inc.
TABLE 356 key information – Illumina, Inc.
TABLE 357 Key Information – Eurofins Scientific Group
TABLE 358 Key Information – Invitae Corporation
TABLE 359 Key Information – OPKO Health, Inc.
TABLE 360 Key Information – Fulgent Genetics
TABLE 361 Key Information – Sema4 OpCo, Inc.
TABLE 362 Key Information – Myriad Genetics, Inc.
TABLE 363 Key Information – Natera Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 5 Recent strategies and developments: Quest Diagnostics
FIG 6 Swot analysis: thermo fisher scientific, inc.
FIG 7 Recent strategies and developments: Sema4 OpCo, Inc.